Homology Medicines Inc Stock Ownership - Who owns Homology Medicines?

Insider buying vs selling

Have Homology Medicines Inc insiders been buying or selling?
Albert SeymourPresident and Chief Executive Officer2023-09-061,448$1.15
Julie JordanChief Medical Officer2023-08-03436$1.39
Julie JordanChief Medical Officer2023-08-031,308$1.39
Julie JordanChief Medical Officer2023-08-03109$1.39
Julie JordanChief Medical Officer2023-08-0299$1.31
Paul AllowayChief Legal Officer and Secretary2023-03-0210,965$1.45
Arthur TzianabosDirector2023-01-0910,616$1.39
Michael Lee BlumChief Commercial Officer2023-01-092,454$1.39
Albert SeymourPresident and Chief Executive Officer2023-01-093,620$1.39
W. Bradford SmithChief Financial and Business Officer and Treasurer2023-01-093,729$1.39

1 of 2

FIXX insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when FIXX insiders and whales buy or sell their stock.

FIXX Shareholders

What type of owners hold Homology Medicines Inc stock?
Arch Venture Fund Viii LP9.96%5,768,694$3.21MInsider
Temasek Holdings Private Ltd9.75%5,650,996$3.15MInstitution
5am Venture Management LLC7.83%4,535,919$2.53MInstitution
James E. Flynn7.06%4,087,305$2.28MInsider
Vanguard Group Inc3.53%2,046,442$1.14MInstitution
Blackrock Inc1.91%1,106,288$616.20kInstitution
Mahendra Shah1.57%909,742$506.73kInsider
Citadel Advisors LLC1.52%879,112$489.67kInstitution
Vivo Capital LLC0.64%370,068$206.13kInstitution
Geode Capital Management LLC0.56%323,459$180.17kInstitution

1 of 3

FIXX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
FIXX29.79%20.14%Net Selling
INAB7.74%15.44%Net BuyingNet Buying

Homology Medicines Stock Ownership FAQ

Who owns Homology Medicines?

Homology Medicines (NASDAQ: FIXX) is owned by 29.79% institutional shareholders, 20.14% Homology Medicines insiders, and 50.06% retail investors. Arch Venture Fund Viii LP is the largest individual Homology Medicines shareholder, owning 5.77M shares representing 9.96% of the company. Arch Venture Fund Viii LP's Homology Medicines shares are currently valued at $3.21M.

If you're new to stock investing, here's how to buy Homology Medicines stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.